Stockreport

Ipsen's Iqirvo wins European approval for primary biliary cholangitis [Yahoo! Finance]

GENFIT S.A. - American Depositary Shares  (GNFT) 
PDF the treatment of primary biliary cholangitis (PBC), becoming the first drug approved for the liver disease in nearly a decade. The approval is for Iqirvo in combinatio [Read more]